{"title":"Proteomic analysis of Substantia nigra proteins in STZ-induced Type-II diabetic rats: A possible link with Parkinson’s disease","authors":"","doi":"10.56042/ijbb.v60i10.214","DOIUrl":null,"url":null,"abstract":"Type-II diabetes mellitus (TIIDM) is a metabolic disorder characterized by high level of glucose in blood due to high secretion of glucose from peripheral tissues, low secretion of insulin or dysfunction of insulin. Parkinson’s disease (PD) is a neurodegenerative disorder characterized by loss of Dopamine in the Substantia nigra of midbrain leading to cause motor dysfunction in affected people. TIIDM and PD have associations with each other as the individuals suffering from TIIDM are at more risk to develop PD in old age. The present study has analyzed eight (08) differentially expressed proteins in the Substantia nigra of TIIDM rat’s brain by using Nano-LC-MS/MS method. Nano-LC-MS/MS is highly recommended technique for the identification & quantification of proteins. RPS27a, PSMC1, PSMa4, ATP8, ATP5f1d and CALM3 were down-regulated while PSMa3 and PRKACa were up-regulated in rat’s brain. These differentially regulated proteins were further analyzed and found to be involved in the oxidative stress, mitochondrial dysfunction, Dopamine pathway, dysfunctional insulin signaling pathway, Ubiquitin regulatory pathways, and Ca2+ signaling pathways of both TIIDM and PD. In conclusion, the current study proposed a link between TIIDM and PD through primary estimated involvement of these proteins in both disorders. However, more in-depth molecular and proteomics studies are needed to be carried out for the possible expression of current proteins as target in the treatment and or prevention of PD in TIIDM patients.","PeriodicalId":13281,"journal":{"name":"Indian journal of biochemistry & biophysics","volume":"35 1","pages":"0"},"PeriodicalIF":1.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of biochemistry & biophysics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56042/ijbb.v60i10.214","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Type-II diabetes mellitus (TIIDM) is a metabolic disorder characterized by high level of glucose in blood due to high secretion of glucose from peripheral tissues, low secretion of insulin or dysfunction of insulin. Parkinson’s disease (PD) is a neurodegenerative disorder characterized by loss of Dopamine in the Substantia nigra of midbrain leading to cause motor dysfunction in affected people. TIIDM and PD have associations with each other as the individuals suffering from TIIDM are at more risk to develop PD in old age. The present study has analyzed eight (08) differentially expressed proteins in the Substantia nigra of TIIDM rat’s brain by using Nano-LC-MS/MS method. Nano-LC-MS/MS is highly recommended technique for the identification & quantification of proteins. RPS27a, PSMC1, PSMa4, ATP8, ATP5f1d and CALM3 were down-regulated while PSMa3 and PRKACa were up-regulated in rat’s brain. These differentially regulated proteins were further analyzed and found to be involved in the oxidative stress, mitochondrial dysfunction, Dopamine pathway, dysfunctional insulin signaling pathway, Ubiquitin regulatory pathways, and Ca2+ signaling pathways of both TIIDM and PD. In conclusion, the current study proposed a link between TIIDM and PD through primary estimated involvement of these proteins in both disorders. However, more in-depth molecular and proteomics studies are needed to be carried out for the possible expression of current proteins as target in the treatment and or prevention of PD in TIIDM patients.
期刊介绍:
Started in 1964, this journal publishes original research articles in the following areas: structure-function relationships of biomolecules; biomolecular recognition, protein-protein and protein-DNA interactions; gene-cloning, genetic engineering, genome analysis, gene targeting, gene expression, vectors, gene therapy; drug targeting, drug design; molecular basis of genetic diseases; conformational studies, computer simulation, novel DNA structures and their biological implications, protein folding; enzymes structure, catalytic mechanisms, regulation; membrane biochemistry, transport, ion channels, signal transduction, cell-cell communication, glycobiology; receptors, antigen-antibody binding, neurochemistry, ageing, apoptosis, cell cycle control; hormones, growth factors; oncogenes, host-virus interactions, viral assembly and structure; intermediary metabolism, molecular basis of disease processes, vitamins, coenzymes, carrier proteins, toxicology; plant and microbial biochemistry; surface forces, micelles and microemulsions, colloids, electrical phenomena, etc. in biological systems. Solicited peer reviewed articles on contemporary Themes and Methods in Biochemistry and Biophysics form an important feature of IJBB.
Review articles on a current topic in the above fields are also considered. They must dwell more on research work done during the last couple of years in the field and authors should integrate their own work with that of others with acumen and authenticity, mere compilation of references by a third party is discouraged. While IJBB strongly promotes innovative novel research works for publication as full length papers, it also considers research data emanating from limited objectives, and extension of ongoing experimental works as ‘Notes’. IJBB follows “Double Blind Review process” where author names, affiliations and other correspondence details are removed to ensure fare evaluation. At the same time, reviewer names are not disclosed to authors.